Literature DB >> 114752

Glucocorticoids and hepatic glycogen metabolism.

W Stalmans, M Laloux.   

Abstract

The steady accumulation of glycogen in fetal rat liver during the last fifth of gestation is elicited by a transient rise in the level of circulating corticosterone. One effect of glucocorticoids is to induce glycogen synthase. The actual deposition of glycogen, however, depends on the appearance of a small amount of glycogen synthase in the active, dephosphorylated form. Induction of glycogen synthase phosphatase by glucocorticoids may explain the latter crucial process. Insulin enhances further the rate of glycogen deposition. The effect of insulin requires a previous exposure of the fetal liver to glucocorticoids. It is exerted on the enzyme interconversion system and appears not to involve new protein synthesis. Administration of glucocorticoids to adult fed or fasted animals causes within 3 h an intensive deposition of glycogen in the liver. This phenomenon is ultimately explained by both an activation of glycogen synthase and an inactivation of glycogen phosphorylase. The latter process may be due to an enhanced activity of phosphorylase phosphatase, or possibly of phosphorylase kinase phosphatase. The activation of glycogen synthase is explained by an enhanced activity of glycogen synthase phosphatase. The latter enzyme is normally profoundly inhibited by phosphorylase a; glucocorticoids cause the appearance in the liver of a protein factor that decreases and eventually cancels this inhibitory effect of phosphorylase a. It remains to be established whether or not some part of the glucocorticoid effect on adult liver is mediated by insulin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 114752     DOI: 10.1007/978-3-642-81265-1_27

Source DB:  PubMed          Journal:  Monogr Endocrinol        ISSN: 0077-1015


  9 in total

Review 1.  Drug-induced endocrine and metabolic disorders.

Authors:  Ronald C W Ma; Alice P S Kong; Norman Chan; Peter C Y Tong; Juliana C N Chan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 2.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

3.  Loss of the hepatic glycogen-binding subunit (GL) of protein phosphatase 1 underlies deficient glycogen synthesis in insulin-dependent diabetic rats and in adrenalectomized starved rats.

Authors:  M J Doherty; J Cadefau; W Stalmans; M Bollen; P T Cohen
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

4.  Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia.

Authors:  Jonathan P German; Joshua P Thaler; Brent E Wisse; Shinsuke Oh-I; David A Sarruf; Miles E Matsen; Jonathan D Fischer; Gerald J Taborsky; Michael W Schwartz; Gregory J Morton
Journal:  Endocrinology       Date:  2010-12-15       Impact factor: 4.736

5.  Biphasic effects of dexamethasone on glycogen metabolism in primary cultured rat hepatocytes.

Authors:  X-F Zheng; L Liu; J Zhou; M-Y Miao; J-R Zhou; D Zhu; Z-F Xia; C-L Jiang
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

Review 6.  Mobilisation of structural proteins during exercise.

Authors:  A Viru
Journal:  Sports Med       Date:  1987 Mar-Apr       Impact factor: 11.136

Review 7.  Regulation of Glucose Homeostasis by Glucocorticoids.

Authors:  Taiyi Kuo; Allison McQueen; Tzu-Chieh Chen; Jen-Chywan Wang
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

8.  Glycogen synthesis in serum-free cultured hepatocytes in response to insulin and dexamethasone.

Authors:  M P Lopez; M J Gomez-Lechon; J V Castell
Journal:  In Vitro       Date:  1984-12

9.  Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo.

Authors:  Nikolaos Nikolaou; Anastasia Arvaniti; Nathan Appanna; Anna Sharp; Beverly A Hughes; Dena Digweed; Martin J Whitaker; Richard Ross; Wiebke Arlt; Trevor M Penning; Karen Morris; Sherly George; Brian G Keevil; Leanne Hodson; Laura L Gathercole; Jeremy W Tomlinson
Journal:  J Endocrinol       Date:  2020-05       Impact factor: 4.286

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.